Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.95B
Enterprise Value4.54B
P/E Ratio-14.46
PEG Ratio0.21
Price/Sales Ratio3.92
Price/Book Ratio1.94
Enterprise/Revenue4.69
Enterprise/EBITDA-32.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.27
Operating Margin-0.28
AD

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.13

Income Statement

Revenue789.42M
Revenue/Share2.63
Gross Profit297.81M
EBITDA-183.87M
Net Income-339.63M
Diluted EPS-1.07

Balance Sheet

Total Cash382.35M
Total Cash/Share1.21
Total Debt979.52M
Total Debt/Equity0.58
Current Ratio0.69
Book Value Per Share5.31

Price History

52-Week Change-28.97
52-Week High17.19
52-Week Low8.93
Moving Average 50 Days11.65
Moving Average 200 Days11.59

Statistics

Average Volume17.97M
Shares Outstanding316.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.13
Last Split Factor3:2
Last Split DateJune 13, 2018
AD